Cover Image
Read Now

Pilocarpine for radiotherapy-Induced dry mouth and dry eyes a review of clinical effectiveness, cost-effectiveness, and guidelines

The objective of this report is to summarize the evidence regarding the clinical effectiveness, cost-effectiveness, and evidence-based guidelines regarding the use of pilocarpine for the treatment of dry mouth and dry eyes caused by radiotherapy for cancer of the head or neck

Bibliographic Details
Main Authors: Marchand, Dave K., McCormack, Suzanne (Author)
Corporate Author: Canadian Agency for Drugs and Technologies in Health Rapid Response Service
Format: eBook
Language:English
Published: Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2020, January 8, 2020
Edition:Version 1.0
Series:CADTH rapid response report: summary with critical appraisal
Subjects:
Canada
Pilocarpine / Therapeutic Use
Dry Eye Syndromes / Drug Therapy
Cost-benefit Analysis
Xerostomia / Drug Therapy
Treatment Outcome
Radiotherapy / Adverse Effects
Guidelines As Topic
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:The objective of this report is to summarize the evidence regarding the clinical effectiveness, cost-effectiveness, and evidence-based guidelines regarding the use of pilocarpine for the treatment of dry mouth and dry eyes caused by radiotherapy for cancer of the head or neck
Physical Description:1 PDF file (22 pages) illustrations

Similar Items